for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-GSK Says ViiV Healthcare Study Shows New Long-Acting HIV Regimen Cabenuva Can Be Used In US Healthcare Practices

July 17 (Reuters) - GlaxoSmithKline PLC:

* GSK-VIIV HEALTHCARE STUDY SHOWS NEW LONG-ACTING HIV REGIMEN CABENUVA CAN BE USED IN BROAD RANGE OF US HEALTHCARE PRACTICES, EVEN DURING COVID-19 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up